The ROMICAT-II trial shows that CT coronary angiography is safe and fast for the exclusion of clinically significant obstructive coronary artery disease in low-risk patients with acute chest pain. Several issues and questions relating to the low prevalence of disease and the actual benefit to patients remain to be answered.
|Number of pages||2|
|Journal||Nature Reviews Cardiology|
|Publication status||Published - 2012|